For most of human history, the people who sat with mushrooms in ceremony already knew something. That something happens in the body, not just the mind. That after the night is over, you carry yourself a little differently. That whatever the medicine touched, it didn't only touch the part of you that thinks.
The science is only now beginning to ask the same question.
In July 2025, a peer-reviewed study published in npj Aging, part of the Nature portfolio, provided the first experimental evidence that psilocybin may extend cellular lifespan and improve survival in aged mice. A few months later, biohacker Bryan Johnson ran what is likely the most heavily quantified self-experiment ever conducted on psilocybin, tracking 249 biomarkers across two ceremonial doses. His systemic inflammation dropped by more than 35%. His microbiome shifted measurably. His brain showed patterns of increased flexibility and reduced rumination that lasted long after the experience ended.
These are very different studies, one peer-reviewed and conducted on cells and mice, the other a single human's quantified self-experiment. Together, they point toward something the people who have sat with this medicine have always intuited: that whatever psilocybin is doing, it isn't just psychological.
Nature study findings
A peer-reviewed 2025 study in npj Aging found that psilocin, the active metabolite of psilocybin, extended the lifespan of human cells by 29% at a 10 micromolar dose, and by 57% at 100 micromolar. Aged mice given psilocybin also showed significantly improved survival.
Researchers at Baylor College of Medicine and Emory University used a validated model of cellular aging called replicative senescence, in which human fetal lung fibroblasts are repeatedly divided until they exhaust their capacity to replicate. Cells exposed to psilocin maintained their ability to divide longer than untreated cells. They didn't become cancerous. They simply aged more slowly.
In a separate experiment, aged mice treated with psilocybin showed improved survival rates compared to untreated controls. The researchers proposed that psilocybin may act as what they called a "geroprotective agent," a compound that protects against the cellular processes of aging itself.
The proposed mechanism connects to something called the psilocybin-telomere hypothesis. Telomeres are the protective caps at the ends of chromosomes that shorten as cells divide and as we age. Chronic stress, depression, and anxiety are all associated with telomere shortening. Psilocybin, with its well-documented effects on these conditions, may protect telomere length, and through that, cellular aging itself.
This is the first experimental evidence to directly test that hypothesis. And the findings supported it.
Bryan Johnson study findings
Bryan Johnson's self-experiment, while not peer-reviewed, ran the most comprehensive biomarker tracking ever attempted around a psilocybin experience, and the results align with what the cellular research is suggesting.
After two doses of psilocybin separated by a month, Johnson reported broad benefits across mental, hormonal, metabolic, and anti-inflammatory systems. His systemic inflammation dropped from "elite" levels to undetectable, a reduction of more than 35%. His microbiome showed measurable shifts that he described as "dramatic." His brain scans showed reduced activity in the prefrontal cortex and command networks during the experience, with patterns of increased connectivity and cognitive flexibility that persisted afterward.
What makes Johnson's experiment notable isn't that he's a single data point, but that he is what scientists call an outlier baseline. Most of his biomarkers were already in the 99th percentile of optimal before the experiment began. He was already eating a near-perfect diet, exercising daily, sleeping eight hours a night, and tracking everything he put into his body. And psilocybin still produced multi-system improvements that none of his other interventions had.
We do not follow Bryan's longevity work, so that doesn't prove anything definitive. But, it does suggest that whatever psilocybin is doing, it may be reaching layers of human biology that diet, exercise, and supplementation alone cannot reach.
Why this matters
This research matters because it suggests psilocybin may be working at a level deeper than mood or perception, touching the cellular machinery of aging itself.
For decades, the conversation around psilocybin has focused almost exclusively on consciousness. The mystical experience. The reduction of depression scores. The shift in worldview. All of that is real and worth taking seriously. But what the cellular research and biomarker data are pointing toward is a parallel story, one happening in the cells, the mitochondria, the inflammatory pathways, the microbial communities of the gut. A story most people who have sat with this medicine could feel was happening, even if they had no language for it.
The body changes after ceremony. The system settles. Something that was running too hot, for too long, comes down a few degrees and stays there. That is now beginning to be measurable.
Whether psilocybin extends human lifespan in any meaningful way is far from settled science. The mouse and cellular studies are early. Bryan Johnson is one person. What we can say is that the picture of what this medicine actually does is becoming larger and more interesting than the conversation of even five years ago.
The container
If psilocybin is acting on cellular aging, inflammation, and microbial balance, then the conditions surrounding ceremony matter even more than we thought.
A medicine doing this much biological work deserves a body that has been prepared to receive it. Sleep. Nutrition. Hydration. Reduced stress in the weeks before. The simple things that have always been part of plant medicine preparation aren't just spiritual practice, they're creating physiological conditions that may shape how the medicine lands and how long its effects hold.
At Ananda Lodge, our preparation protocols begin weeks before guests arrive. This isn't about following rules. It's about giving the medicine the best possible conditions to do whatever it's going to do, and increasingly, that includes biological work we're only beginning to understand.
If curiosity is pulling at you
Most people who come to Ananda for their first psilocybin retreat have been thinking about it for a while. They've read articles. They've watched documentaries. They've heard a friend talk about it. Something has been quietly pulling on them, and the conversation around psilocybin and longevity is making the pull a little louder.
If that's where you are, that's worth paying attention to.
We hold psilocybin retreats throughout the year at Ananda Lodge, small group containers of maximum 10 guests, with the deep preparation, somatic support, and three-month integration that turns an experience into something that actually changes how you live afterward. The retreat is not the medicine alone. It's the container around it. And the container is what makes the difference between something powerful and something that genuinely lasts.
See all upcoming retreats →
Frequently Asked Questions
Does psilocybin extend lifespan?
A 2025 peer-reviewed study in npj Aging found that psilocybin extended cellular lifespan in human cells by 29 to 57 percent depending on dose, and improved survival in aged mice. This is early experimental evidence and has not yet been replicated in humans, but it provides the first direct test of the hypothesis that psilocybin may have geroprotective effects.
What did Bryan Johnson's psilocybin experiment find?
In a 2026 self-experiment tracking 249 biomarkers, Bryan Johnson reported broad improvements across mental, hormonal, metabolic, and anti-inflammatory systems after two doses of psilocybin. Notably, his systemic inflammation dropped by more than 35% and his microbiome shifted measurably. This is one person's data and is not peer-reviewed, but it represents the most comprehensive biomarker tracking ever conducted around a psilocybin experience.
What is the psilocybin-telomere hypothesis?
The psilocybin-telomere hypothesis proposes that psilocybin may protect or extend telomere length, the protective caps at the ends of chromosomes that shorten with age and chronic stress. Because depression, anxiety, and chronic stress are linked to telomere shortening, and because psilocybin reduces these conditions, the hypothesis suggests psilocybin may slow biological aging through this pathway. The 2025 Nature study provided the first experimental evidence supporting this idea.
Is psilocybin safe?
Psilocybin has a well-established safety profile when used in appropriate doses with proper screening and facilitation. At Ananda Lodge, every guest goes through a thorough intake and screening process, and ceremonies are held with experienced facilitators in a trauma-informed container. People with certain mental health conditions or on specific medications may not be candidates. This is assessed during your intake.
What does a psilocybin retreat at Ananda Lodge include?
Our psilocybin retreats include multiple ceremonies held in a small group of maximum 10 guests, deep preparation beginning weeks before arrival, somatic support throughout, and three months of integration support after you leave. The container is designed to translate what opens in the medicine into lasting change.